Recognition of Guanine-Guanine Mismatches
J. Am. Chem. Soc., Vol. 123, No. 50, 2001 12657
8.8 Hz), 7.98 (d, 2 H, J ) 8.4 Hz), 7.25 (d, 2 H, J ) 8.4 Hz), 3.65 (t,
4 H, J ) 6.8 Hz), 2.77 (t, 4 H), 2.74 (s, 6 H), 1.37 (s, 9 H); 13C NMR
(CDCl3, 100 MHz) δ 171.2, 163.2, 155.4, 154.4, 153.9, 139.4, 121.8,
118.8, 115.0, 80.5, 44.8, 37.7, 28.8, 26.0; FABMS (NBA), m/e 544
[(M + H)+]; HR-FABMS calcd for C29H34O4N7 [(M + H)+], 544.2645;
found, 544.2670.
To a solution of 9 (1.5 g, 2.5 mmol) in dry DMF (5 mL) was added
2-amino-7-methyl-1,8-naphthyridine (180 mg, 1.1 mmol) and diiso-
propylethylamine (163 mg, 1.26 mmol). The mixture was stirred at
room temperature for 15 h. The solvent was evaporated to dryness,
and the crude residue was purified by silica gel column chromatography
to give 11 (1.29 g, 90%) as a pale yellow solid: 1H NMR (CDCl3, 400
MHz) δ 9.01 (br, 1 H), 8.44 (d, 1 H, J ) 8.8 Hz), 8.12 (d, 1 H, J )
8.8 Hz), 7.99 (d, 1 H, J ) 8.0 Hz), 7.26 (d, 1 H, J ) 8.0 Hz), 3.66 (m,
4 H), 2.90 (m, 2 H), 2.74 (m, 2 H), 2.73 (s, 3 H), 1.42 (s, 9 H); FABMS
(NBA), m/e 569 [(M + H)+]; HR-FABMS calcd for C26H26O5N4F5
[(M + H)+], 569.1821; found, 569.1827. To a solution of 11 (587 mg,
1.0 mmol) in dry DMF (2 mL) was added 2-aminoquinoline (180 mg,
1.2 mmol) and diisopropylethylamine (160 mg, 1.2 mmol). The mixture
was stirred at room temperature for 48 h. The solvent was evaporated
to dryness, and the crude residue was purified by silica gel column
chromatography to give 12 (187 mg, 34%) as a pale yellow solid: 1H
NMR (CDCl3, 400 MHz) δ 8.95 (s, 1 H), 8.73 (s, 1 H), 8.44 (d, 1 H,
J ) 8.8 Hz), 8.27 (d, 1 H, J ) 8.0 Hz), 8.12 (d, 1 H, J ) 8.8 Hz), 8.07
(d, 1 H, J ) 8.8 Hz), 7.95 (d, 1 H, J ) 8.0 Hz), 7.75 (d, 1 H, J ) 8.8
Hz), 7.71 (d, 1 H, J ) 8.0 Hz), 7.61 (t, 1 H, J ) 7.0 Hz), 7.40 (t, 1 H,
J ) 7.0 Hz), 7.19 (d, 1 H, J ) 8.0 Hz), 3.64 (m, 2 H), 3.63 (m, 2 H),
2.74 (m, 2 H), 2.73 (m, 2 H), 2.72 (s, 3 H), 1.38 (s, 9 H); 13C NMR
(CDCl3, 100 MHz) δ 170.6, 170.4, 163.2, 155.4, 154.4, 153.3, 150.8,
146.5, 139.1, 138.6, 136.5, 129.9, 127.5, 127.3, 126.9, 125.1, 121.6,
118.6, 114.4, 114.3, 80.4, 77.2, 44.7, 37.3, 30.9, 28.3, 25.5; FABMS
(NBA), m/e 529 [(M + H)+]; HR-FABMS calcd for C29H33O4N6 [(M
+ H)+], 529.2561; found, 529.2565.
N-(7-Methylpyridino[3,2-e]pyridin-2-yl)-3-((2-(N-(2-quinolyl)car-
bamoyl)ethyl)amino)propanamide (4). To a solution of 12 (116 mg,
0.22 mmol) in CHCl3 (3 mL) was added ethyl acetate containing 4 M
HCl (2 mL) at 0 °C, and the mixture was stirred at room temperature
for 0.5 h. The solvent was evaporated to dryness to give hydrochloride
of 4 (quantitative yield) as a white solid: 1H NMR (CD3OD, 400 MHz)
δ 8.94 (d, 1 H, J ) 8.4 Hz), 8.92 (d, 1 H, J ) 8.4 Hz), 8.70 (d, 1 H,
J ) 8.8 Hz), 8.65 (d, 1 H, J ) 8.8 Hz), 8.21 (d, 1 H, J ) 8.4 Hz), 8.18
(d, 1 H, J ) 8.4 Hz), 8.05 (t, 1 H, J ) 7.2 Hz), 7.85 (d, 1 H, J ) 8.4
Hz), 7.83 (t, 1 H, J ) 7.2 Hz), 7.65 (d, 1 H, J ) 8.4 Hz), 3.60 (t, 2 H,
J ) 6.4 Hz), 3.55 (t, 2 H, J ) 6.4 Hz), 3.31 (t, 2 H, J ) 6.4 Hz), 3.23
(t, 2 H, J ) 6.4 Hz), 2.99 (s, 3 H); 13C NMR (CD3OD, 100 MHz) δ
174.5, 172.4, 161.4, 158.3, 150.6, 148.6, 147.5, 145.2, 141.5, 135.4,
134.2, 130.2, 129.5, 126.5, 123.7, 121.5, 118.8, 118.2, 114.9, 44.6,
44.0, 33.9, 33.8, 20.8; FABMS (NBA), m/e 429 [(M + H)+]; HR-
FABMS calcd for C24H25O2N6 [(M + H)+], 429.2037; found, 429.2038.
Isothermal Titration Calorimetry (ITC). ITC titration experiments
were performed on a VP MicroCalorimetry System. The experiment
was conducted by adding 2 (70 µM) every 3 min into a sodium
cacodylate buffer (10 mM, pH 7.0) containing NaCl (100 mM) and
11-mer G-G mismatch-containing duplex d(CTA ACG GAA TG)/
d(CAT TCG GTT AG) (GG2) (0 or 4 µM) at 25 °C.
N-(7-Methylpyridino[3,2-e]pyridin-2-yl)-3-((2-(N-(7-methylpyri-
dino[3,2-e]pyridin-2-yl)carbamoyl)ethyl)amino)propanoate (2). To
a solution of 8 (50 mg, 0.09 mmol) in ethyl acetate (3 mL) was added
ethyl acetate containing 4 M HCl (1.5 mL) at 0 °C, and the mixture
was stirred at room temperature for 2 h. The solvent was evaporated
to dryness to give the hydrochloride of 2 (quantitative yield) as a white
solid. The hydrochloride of 2 was dissolved in H2O and extracted into
CHCl3 by the addition of 28% aqueous ammonia solution. The organic
layer was dried over MgSO4, and the solvent was evaporated in vacuo
to give 2 (34 mg, 84%) as a pale yellow solid: 1H NMR (CDCl3, 400
MHz) δ 8.39 (d, 2 H, J ) 8.8 Hz), 8.03 (d, 2 H, J ) 8.8 Hz), 7.93 (d,
2 H, J ) 8.0 Hz), 7.21 (d, 2 H, J ) 8.0 Hz), 3.10 (t, 4 H, J ) 6.0 Hz),
2.77 (t, 4 H, J ) 6.0 Hz), 2.72 (s, 6 H); 13C NMR (CDCl3, 100 MHz)
δ 171.9, 163.0, 154.6, 153.7, 138.7, 136.3, 121.3, 118.4, 114.6, 44.6,
36.8, 25.5; FABMS (NBA), m/e 444 [(M + H)+]; HR-FABMS calcd
for C24H26O2N7 [(M + H)+], 444.2146; found, 444.2148.
4-((tert-Butoxy)carbonylamino)-N,N-bis(2-(N-(7-methylpyridino-
[3,2-e]pyridin-2-yl)carbamoyl)ethyl)butanamide (9). To a solution
of 2 (200 mg, 0.23 mmol) dissolved in DMF (5 mL) were added
pentafluorophenyl 4-(tert-butoxy)carbonylaminobutylate (100 mg, 0.27
mmol) and diisopropylethylamine, and the solution was stirred over-
night. Solvents were evaporated, and the residue was chromatographed
on a silica gel column (chloroform-methanol ) 50:1) to give 9 (223
1
mg, 87%); H NMR (400 MHz, CDCl3) δ 10.0 (broad, 1 Η), 9.54
(broad, 1 H), 8.37 (d, 2 H, J ) 8.9 Hz), 8.06 (d, 2 H, J ) 8.8 Hz), 7.94
(d, 1 H, J ) 8.1 Hz), 7.91 (d, 1 H, J ) 8.3 Hz), 7.22 (d, 1 H, J ) 8.2
Hz), 7.18 (d, 1 H, J ) 8.1 Hz), 5.21 (broad, 1 H), 3.76 (broad, 2 H),
3.66 (broad, 2 H), 3.08 (broad, 2 H), 2.82 (broad, 4 H), 2.69 (s, 6 H),
2.41 (t, 2 H, J ) 7.1), 1.78 (broad, 2 H), 1.35 (s, 9 H); 13C NMR (100
MHz, CDCl3) δ 173.2, 171.3, 170.2, 163.2, 163.0, 156.1, 153.5, 139.1,
139.0, 136.4, 136.3, 121.6, 121.4, 118.5, 118.4, 114.6, 78.9, 77.3, 77.2,
77.0, 76.7, 44.6, 42.1, 40.0, 36.8, 36.2, 30.2, 28.4, 25.2, 25.5, 25.3;
FABMS (NBA), m/e (%) 629 [(M + H)+] (40); HR-FABMS calcd for
C33H41O4N4F5, 629.3200; found, 629.3193.
4-Amino-N,N-bis(2-(N-(7-methylpyridino[3,2-e]pyridin-2-yl)car-
bamoyl)ethyl)butanamide (3). To a solution of 9 (220 mg, 0.35 mmol)
in chloroform (1 mL) was added 3 N HCl in AcOEt (5 mL) at 0 °C,
and the solution was stirred at room temperature for 30 min. The
resulting solution was evaporated. Water and aqueous ammonia were
added to the solution (pH > 7), and the resulting solution was extracted
with chloroform and dried with MgSO4. The solution was evaporated
to give 3 (167 mg, 90%). 1H NMR (400 MHz, CDCl3) δ 7.76 (broad,
1 Η), 7.68-7.61 (3 H), 7.54 (d, 1 H, J ) 9.0) 7.43 (d, 1 H, J ) 8.2),
7.00 (d, 1 H, J ) 8.2), 6.81 (d, 1 H, J ) 8.0), 3.63 (t, 2 H, J ) 5.9),
3.56 (t, 2 H, J ) 6.2), 2.95 (t, 2 H, J ) 7.5), 2.71-2.62 (7 H), 2.40 (s,
3 H), 2.35 (s, 3 H), 1.87 (p, 2 H, J ) 7.5); 13C NMR (100 MHz, CDCl3)
δ 183.1, 178.0, 176.0, 174.9, 166.0, 165.8, 155.1, 154.9, 142.4, 142.2,
140.1, 124.7, 124.5, 120.8, 116.6, 116.6, 47.4, 46.3, 41.8, 38.6, 38.4,
32.7, 26.6, 25.8, 25.2; FABMS (NBA), m/e (%) 529 [(M + H)+] (40);
HR-FABMS calcd C29H33N9O3, 529.2676; found, 529.2694.
Pentafluorophenyl-3-((tert-butoxy)-N-(2-((pentafulorophenyl)oxy-
carbonyl)ethyl)carbonylamino)propanoate (10). Compound 5 was
converted to N-(tert-butoxycarbonyl)iminobis(propionic acid) as de-
scribed above. To a solution of N-(tert-butoxycarbonyl)iminobis-
(propionic acid) (6.2 g, 24 mmol) in DMF were added pentafluorophe-
nol (10.5 g, 57 mmol) and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide
hydrochloride (10.9 g, 57 mmol). The mixture was stirred for 24 h at
room temperature. The solvent was evaporated, and the crude product
was suspended in CHCl3. The organic layer was washed with H2O and
dried over MgSO4. The solvent was evaporated in vacuo, and the crude
residue was purified by silica gel column chromatography to give 9
(8.0 g, 57%) as a white solid: 1H NMR (CDCl3, 400 MHz) δ 3.65 (m,
4 H), 2.99 (m, 2 H), 2.93 (m, 2 H), 1.47 (s, 9 H); FABMS (NBA), m/e
594 [(M + H)+]; HR-FABMS calcd for C23H18O6NF10 [(M + H)+],
594.0973; found, 594.0971.
NMR Measurements of 2-GG1 Complex. DNA duplex GG1 (1
mM in H2O) both in free and complex states with 2 was pipetted into
a Shigemi microtube. The NMR experiments were performed on Bruker
DRX-600 and JEOL R-400 spectrometers. The total correlated spec-
troscopy (TOCSY) spectra were recorded with mixing time of 60 ms,
and nuclear Overhauser effect spectroscopy (NOESY) spectra were
recorded with mixing time of 300 ms. Total of 32 (TOCSY) and 64
(NOESY) transients were acquired with a recycle delay of 1.2 s at 17
°C. The 31P NMR spectra were taken with proton decoupling sequence
during acquisition time.
Acknowledgment. We thank Mr. Junji Nakamura and Mr.
Yuji Hirohata of Nihon SiberHegner Co., Ltd. for ITC measure-
ments. This research was supported in part by a grant-in-aid
for scientific research on priority areas (C) “medical genome
science” from the Ministry of Education, Science, Sports and
Culture of Japan.
Supporting Information Available: Thermal profile of
1
imino protons in H NMR of GG1 and the 2-GG1 complex
(PDF). This material is available free of charge via the Internet
3-((tert-Butoxy)-N-(2-(N-(2-quinolyl)carbamoyl)ethyl)carbonyl-
amino)-N-(7-methylpyridino[3,2-e]pyridin-2-yl)propanamide (12).
JA0109186